|
Two novel therapeutic candidates for the treatment and reversal of various morbidities associated with diabetes mellitus, obesity, and gastrointestinal motility disorders.
BACKGROUND
According to data from the World Health Organization, there are over 425 million diabetic patients in the world, and that number has been rapidly increasing as the prevalence of obesity also increases. Obesity and diabetes are closely interconnected as 90% of diabetics are also obese. People with type 1 diabetes (T1D) don’t produce...
Published: 5/5/2020
|
Updated: 5/5/2020
|
Inventor(s): Seungil Ro
Keywords(s):
Category(s): Healthcare & Pharmaceuticals
|
